More on COYA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Coya Therapeutics (NQ:COYA)
Delayed: 3.94 -0.2 (4.83%)
Prev. Close $4.14  
Open$4.08 
52 Wk High$ 
52 Wk Low$ 
Day High$4.25 
Day Low$3.94 
P/E N/A  
EPS$ 
Volume188,647 

Friends, Peers and Foes (?): AVIR, ABBV, CARM, LLY, MEIP (more...)

Oct 14, 2026 08:30 AM Form 8-K Coya Therapeutics, Inc. For: Oct 14
Oct 14, 2026 08:00 AM Coya plans open-label extension of ALS trial, delays FTD study
Oct 14, 2026 08:00 AM Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Oct 13, 2026 08:00 AM Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Oct 6, 2026 07:05 AM H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
Oct 5, 2026 08:30 AM Form 8-K Coya Therapeutics, Inc. For: Oct 05
Oct 5, 2026 08:00 AM Coya Therapeutics completes enrollment in Phase 2/3 ALS trial
Oct 5, 2026 08:00 AM Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Sep 25, 2026 06:51 AM H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
Sep 15, 2026 08:15 AM Form 8-K Coya Therapeutics, Inc. For: Sep 15
View All Articles

Entities mentioned with COYA

View All Entities